Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Revenue (2019 - 2025)

Historic Revenue for Neurogene (NGNE) over the last 6 years, with Q1 2025 value amounting to -$80000.0.

  • Neurogene's Revenue rose 8671.1% to -$80000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was -$80000.0, marking a year-over-year decrease of 12476.78%. This contributed to the annual value of $925000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q1 2025, Neurogene's Revenue is -$80000.0, which was up 8671.1% from $925000.0 recorded in Q2 2024.
  • In the past 5 years, Neurogene's Revenue registered a high of $925000.0 during Q2 2024, and its lowest value of -$602000.0 during Q1 2024.
  • Moreover, its 3-year median value for Revenue was -$41500.0 (2023), whereas its average is $60000.0.
  • Per our database at Business Quant, Neurogene's Revenue crashed by 1996666.67% in 2024 and then surged by 8671.1% in 2025.
  • Quarter analysis of 3 years shows Neurogene's Revenue stood at -$3000.0 in 2023, then skyrocketed by 30933.33% to $925000.0 in 2024, then crashed by 108.65% to -$80000.0 in 2025.
  • Its Revenue stands at -$80000.0 for Q1 2025, versus $925000.0 for Q2 2024 and -$602000.0 for Q1 2024.